ALZpath, Inc.
PrivateLast Round
Seed Round
Jul 21, 2026
Total Funding Raised
$1.9M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
ALZpath, Inc. is a biotechnology company that develops diagnostic tools and solutions for Alzheimer's disease, centered around its proprietary pTau217 antibody for blood-based testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALZpath, Inc. Comparables
Compare ALZpath, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AgenT | 79% | |
| C2N Diagnostics | 77% | |
| Veravas | 77% |
ALZpath, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 21, 2026 | ||||
| Seed | May 21, 2024 | ||||
| Grant | Jul 18, 2023 |
ALZpath, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartUp Health | Grant, Seed, Seed Round |
| Stead Impact Ventures and Foundation | Grant, Seed, Seed Round |
| Alzheimer's Drug Discovery Foundation | Seed Round, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 85% MoM.
- Jul 21, 2026
Raised $8.4M in Seed funding.
Recent news
Latest coverage and updates
- partners_withJul 22, 2026
ALZpath Inc. partners with Quanterix Corporation.
- attends_eventJul 13, 2026
ALZpath Inc. attended event AAIC 2026 on Jul 12th '26.
- partners_withJun 24, 2026
ALZpath Inc. partnered with Abbott on Jun 24th '26.
- is_developingJun 24, 2026
ALZpath Inc. is developing Alzheimer's blood test on Jun 24th '26.
- partners_withJun 24, 2026
ALZpath Inc. partnered with Abbott on Jun 24th '26.
ALZpath, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ALZpath, Inc.'s valuation, stock price, and market status.
Is ALZpath, Inc. a public or private company?
ALZpath, Inc. is a private company.
What is the current stock price of ALZpath, Inc.?
ALZpath, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is ALZpath, Inc. worth (valuation)?
Valuation information for ALZpath, Inc. is not publicly available.
Can I buy ALZpath, Inc. stock?
ALZpath, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ALZpath, Inc.'s last funding round?
ALZpath, Inc.'s most recent funding round was Seed on July 18, 2023.
Who are the main investors in ALZpath, Inc.?
Key investors in ALZpath, Inc. include Alzheimer's Drug Discovery Foundation.
Will ALZpath, Inc. IPO soon?
No public IPO plans have been announced for ALZpath, Inc..
How can I track ALZpath, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ALZpath, Inc.'s secondary market activity and sign up for updates.